Mayo researchers to announce new findings about promising early-stage breast cancer treatment
A study led by a Mayo Clinic medical oncologist and conducted by the North Central Cancer Treatment Group (NCCTG) provides important new data about the effectiveness and safety of a breast cancer treatment combining chemotherapy and a drug called trastuzumab (Herceptin).
Full Article: http://www.eurekalert.org/pub_releases/2005-05/mc-mrt051305.php